My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.

    Sattar N, McConnachie A, Ford I, Gaw A, Cleland SJ, Forouhi NG, McFarlane P, Shepherd J, Cobbe S, Packard C.

    Diabetes. 2007 Apr;56(4):984-91.PMID: 17395744 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

    Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J; west of Scotland coronary prevention study.

    Diabetes. 2004 Nov;53(11):2855-60.PMID: 15504965 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.

    Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP.

    Diabetes. 2004 Jan;53(1):160-5.PMID: 14693710 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

    Haffner SM, Mykkänen L, Festa A, Burke JP, Stern MP.

    Circulation. 2000 Mar 7;101(9):975-80.PMID: 10704163 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

    Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H.

    Diabetes Care. 2008 Jan;31(1):165-9. Epub 2007 Oct 12.PMID: 17934148 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

    Kim CH, Park JY, Lee KU, Kim JH, Kim HK.

    Diabetes Metab Res Rev. 2009 Jan;25(1):64-9.PMID: 19065605 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.

    Jin HB, Gu ZY, Yu CH, Li YM.

    Hepatobiliary Pancreat Dis Int. 2005 Aug;4(3):389-92.PMID: 16109522 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand.

    Jiamjarasrangsi W, Sangwatanaroj S, Lohsoonthorn V, Lertmaharit S.

    Diabetes Metab. 2008 Jun;34(3):283-9. Epub 2008 May 16.PMID: 18486512 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

    Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E; Mexico City diabetes study.

    Diabetes Care. 2005 Jul;28(7):1757-62.PMID: 15983331 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.

    Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, Scaldaferri L, Di Bartolo P, Melandri P, Dei Cas A, Zavaroni I, Marchesini G.

    J Endocrinol Invest. 2008 Feb;31(2):146-52.PMID: 18362506 [PubMed - indexed for MEDLINE]Related articles

    13.

    Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.

    Sato KK, Hayashi T, Nakamura Y, Harita N, Yoneda T, Endo G, Kambe H.

    Diabetes Care. 2008 Jun;31(6):1230-6. Epub 2008 Mar 3.PMID: 18316395 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevalence of abnormal serum alanine aminotransferase levels in type 2 diabetic patients in Iran.

    Meybodi MA, Afkhami-Ardekani M, Rashidi M.

    Pak J Biol Sci. 2008 Sep 15;11(18):2274-7.PMID: 19137840 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.

    Nimitphong H, Phongkitkarun S, Rattarasarn C, Kongsooksai A, Chanprasertyothin S, Bunnag PA, Puavilai G.

    Metabolism. 2008 May;57(5):644-9.PMID: 18442627 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.

    Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S.

    Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):253-9.PMID: 18074733 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

    Clin Ther. 2008 May;30(5):858-67.PMID: 18555933 [PubMed - indexed for MEDLINE]Related articles

    19.

    Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.

    Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS.

    Metabolism. 2007 Jun;56(6):792-8.PMID: 17512312 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus.

    Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M.

    Addict Biol. 2004 Mar;9(1):53-8.PMID: 15203439 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity